mHealth Wearables Drive Disruption in Diabetic Care as Global Sufferers Reach Half Billion

ABI Research Forecasts Nine Million Continuous Glucose Monitor (CGM) Shipments by 2021

NEW YORK, Oct. 13, 2016 /PRNewswire/ -- This year, the global diabetic population crossed half a billion, and it continues to grow. In response, device manufacturers, healthcare providers, and patients are looking for ways to manage this long-term chronic disease in an efficient and unobtrusive way. In its examination of both current and in-development technologies geared toward extending effective diabetes care, ABI Research finds wearable continuous glucose monitoring devices are paramount. Between now and 2021, more than nine million wearable CGM devices will ship, as they increasingly gain support and challenge finger prick glucose meters.

Logo - http://photos.prnewswire.com/prnh/20151014/276887LOGO

"mHealth wearable device manufacturers integrated the new, non-invasive CGMs and insulin pumps with cloud services, analytics tools, and predictive software to provide new types of pattern analysis in near real time," says Ryan Harbison, Research Analyst at ABI Research.

The overall diabetic testing market, which includes glucose meters and test strips, will exceed $17 billion in 2021, up from $12 billion in 2016. CGM revenues will grow at a CAGR of 41% over the same period. Existing glucose meter device vendors, such as Bayer and Johnson & Johnson, will increasingly have to compete against CGM specialists, including Abbott, Dexcom, and Medtronic.

"Medtronic has a substantial advantage with its MiniMed CGM system, Abbott focuses on the European market, and Dexcom innovates on existing CGM devices to create all-in-one experiences through mobile integrations," concludes Harbison. "Glucose meter manufacturers, such as Johnson & Johnson and Roche Diagnostics, can further disrupt this market by developing new form factors, such as contact lenses and skin patches, to create less invasive and more accurate monitoring devices."     

These findings are from ABI Research's Diabetes: Wearable mHealth Device Market Overview (https://www.abiresearch.com/market-research/product/1018561-diabetes-wearable-mhealth-device-market-ov/). This report is part of the company's Smart Home (https://www.abiresearch.com/market-research/practice/connected-home/) and Wearables & Devices (https://www.abiresearch.com/market-research/practice/wearables-devices/) sectors, which include research, data, and analyst insights.

About ABI Research

ABI Research stands at the forefront of technology market research, providing business leaders with comprehensive research and consulting services to help them implement informed, transformative technology decisions. Founded more than 25 years ago, the company's global team of senior and long-tenured analysts delivers deep market data forecasts, analyses, and teardown services. ABI Research is an industry pioneer, proactively uncovering ground-breaking business cycles and publishing research 18 to 36 months in advance of other organizations. For more information, visit www.abiresearch.com.

Related Links

http://www.abiresearch.com